The opposite association of HRAS and KRAS mutations with clinical variables of bladder cancer
HRAS, KRAS and NRAS gene products belong to the superfamily of small GTPases. These proteins regulate cellular response to extracellular stimuli by means of activation of different signaling pathways. Although the role of RAS gene mutations in the pathogenesis of various human cancers has been estab...
Main Authors: | M. P. Smal, A. I. Rolevich, T. N. Nabebina, S. A. Krasny, R. I. Goncharova |
---|---|
Format: | Article |
Language: | English |
Published: |
Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences
2015-12-01
|
Series: | Vavilovskij Žurnal Genetiki i Selekcii |
Subjects: | |
Online Access: | https://vavilov.elpub.ru/jour/article/view/457 |
Similar Items
-
Poor Prognosis of Pulmonary Adenosquamous Carcinoma with NRAS and HRAS Double Mutation
by: Zhao J, et al.
Published: (2021-02-01) -
Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck
by: Eiichi Sasaki, et al.
Published: (2020-04-01) -
Clinical significance of HRAS and KRAS genes expression in patients with non–small-cell lung cancer - preliminary findings
by: Milena Pązik, et al.
Published: (2021-02-01) -
The Role of Wild-Type RAS in Oncogenic RAS Transformation
by: Erin Sheffels, et al.
Published: (2021-04-01) -
High frequency of the HRAS oncogene codon 12 mutation in Macedonian patients with urinary bladder cancer
by: Sasho Panov, et al.
Published: (2004-01-01)